ロード中...
Gold nanoparticles-loaded anti-miR221 enhances antitumor effect of sorafenib in hepatocellular carcinoma cells
Objective: Currently, sorafenib is the main systemic chemotherapy drug for advanced stage of hepatocellular carcinoma (HCC). However, emerging data from some clinical HCC patients indicates that sorafenib alone has only moderate antitumor efficacy, and could not inhibit metastasis and progression of...
保存先:
| 出版年: | Int J Med Sci |
|---|---|
| 主要な著者: | , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Ivyspring International Publisher
2019
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6909811/ https://ncbi.nlm.nih.gov/pubmed/31839741 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.7150/ijms.37427 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|